Long COVID Linked to Abnormal Uterine Bleeding

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 17, 2025.

via HealthDay

WEDNESDAY, Sept. 17, 2025 -- Long COVID is associated with abnormal uterine bleeding (AUB), but not with impaired ovarian function, according to a study published online Sept. 16 in Nature Communications.

Jacqueline A. Maybin, M.B.Ch.B., Ph.D., from the University of Edinburgh in the United Kingdom, and colleagues examined whether COVID is linked to AUB and whether long COVID symptoms vary with the menstrual cycle in a U.K. population: 9,423 never infected, 1,048 with long COVID, and 1,716 who had recovered from acute COVID.

The researchers found that long COVID participants reported increased menstrual volume, duration, and intermenstrual bleeding compared with those never infected, while minimal menstrual disruption was reported for those who recovered from acute COVID. On examination of long COVID symptoms across the menstrual cycle in 54 women, severity was highest during the perimenstrual and proliferative phases. Compared with no COVID, in long COVID, serum 5α-dihydrotestosterone was higher and endometrial androgen receptors were lower. No significant differences were seen in other ovarian hormones. Increased menstrual inflammation was seen with long COVID on serum cytokine profiling, and immune cell aggregates were seen in menstrual endometrium.

"Based on our findings, we recommend future investigation of specific treatments for AUB in those with long COVID, consideration of the menstrual cycle in future long COVID biomarker development, and a focus on female-specific treatments for long COVID," the authors write.

Several authors disclosed ties to the pharmaceutical and medical technology industries.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-09-18 16:18

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords